Oxygen, Hyperbaric / HO-1 Cancer Research Results

Oxy, Oxygen, Hyperbaric: Click to Expand ⟱
Features: Therapy
Hyperbaric oxygen (HBO) therapy is a treatment where patients breathe 100% oxygen inside a pressurized chamber.(typically 1.5–3.0 ATA) This approach increases the oxygen concentration in the blood and tissues.
Its strongest evidence base is:
-Radiation enhancement (oxygen fixation)
-Treatment of radiation necrosis
-Wound healing in oncology patients
Enhanced Oxygenation of Tumors:
-Many tumors are hypoxic (low in oxygen), which can make them more resistant to radiation and some forms of chemotherapy. Enhanced oxygenation through HBO may help overcome this hypoxia.
Increased oxygen levels can lead to the formation of reactive oxygen species (ROS), which may damage cancer cells and sensitize them to treatment.

Synergistic Effects with Radiation Therapy:
-Oxygen acts as a radiosensitizer. Radiation-induced DNA damage can be more effective in the presence of oxygen, potentially improving the efficacy of radiotherapy.
Some studies have explored combining HBO with radiotherapy to overcome radioresistance in hypoxic tumor regions.

Improved Delivery of Chemotherapeutic Agents:
-Elevated tissue oxygenation might enhance the delivery and efficacy of certain chemotherapeutic drugs, although this area is still under investigation.

Potential Immune Modulation:
-There is ongoing research into whether HBO can modulate the tumor microenvironment in a way that is more favorable for anti-tumor immune responses.

Possible problems:
-Implanted device (such as an insulin pump or pacemaker)
-Avoid with recent perforated ear drum
-Pneumothorax
-Wait for 4 wks after chemo?


Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Tumor hypoxia reduction Hypoxia ↓; HIF-1α signaling ↓ (context-dependent) Tissue oxygenation ↑ P, R Microenvironment normalization Elevated dissolved oxygen increases tumor pO₂, potentially reducing hypoxia-driven survival programs.
2 Radiation sensitization (oxygen fixation effect) Radiotherapy efficacy ↑ — R DNA damage amplification Oxygen stabilizes radiation-induced DNA radicals, increasing double-strand break lethality.
3 ROS generation (hyperoxia-driven) ROS ↑ (transient); oxidative stress ↑ ROS ↑; antioxidant response ↑ P, R Redox amplification Elevated O₂ increases mitochondrial and enzymatic ROS production; magnitude depends on exposure pressure and duration.
4 NRF2 antioxidant response Adaptive NRF2 activation ↑ (reported) NRF2 ↑; antioxidant enzymes ↑ R, G Redox adaptation Repeated hyperoxic exposure can induce antioxidant defense systems; may influence redox-sensitive therapies.
5 HIF-1α / hypoxia signaling modulation HIF-1α ↓ (acute hyperoxia); VEGF modulation Hypoxia signaling ↓ R Hypoxia pathway suppression Reduced hypoxia may decrease glycolytic shift and angiogenic drive in some tumors.
6 Angiogenesis modulation VEGF modulation (context-dependent) Wound-healing angiogenesis ↑ G Vascular remodeling HBOT stimulates angiogenesis in ischemic tissue; tumor angiogenic response varies by context.
7 Immune modulation Innate immune activity modulation Neutrophil function ↑; inflammation modulation R Inflammatory modulation Hyperoxia can alter cytokine signaling and leukocyte behavior.
8 Combination therapy interaction May enhance radiotherapy; effects with chemo variable — R, G Adjunctive leverage Most consistent evidence supports radiosensitization; chemotherapy interactions are drug-specific.
9 Safety constraints — Oxygen toxicity (CNS/pulmonary); barotrauma risk — Exposure limitation High-pressure or prolonged exposure can cause oxygen toxicity seizures or lung injury.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (hyperoxia; ROS surge)
  • R: 30 min–3 hr (HIF modulation; radiation sensitization window)
  • G: >3 hr (angiogenesis remodeling; adaptive antioxidant response)
HO-1, HMOX1: Click to Expand ⟱
Source:
Type:
(Also known as Hsp32 and HMOX1)
HO-1 is the common abbreviation for the protein (heme oxygenase‑1) produced by the HMOX1 gene.
HO-1 is an enzyme that plays a crucial role in various cellular processes, including the breakdown of heme, a toxic molecule. Research has shown that HO-1 is involved in the development and progression of cancer.
-widely regarded as having antioxidant and cytoprotective effects
-The overall activity of HO‑1 helps to reduce the pro‐oxidant load (by degrading free heme, a pro‑oxidant) and to generate molecules (like bilirubin) that can protect cells from oxidative damage

Studies have found that HO-1 is overexpressed in various types of cancer, including lung, breast, colon, and prostate cancer. The overexpression of HO-1 in cancer cells can contribute to their survival and proliferation by:
  Reducing oxidative stress and inflammation
  Promoting angiogenesis (the formation of new blood vessels)
  Inhibiting apoptosis (programmed cell death)
  Enhancing cell migration and invasion
When HO-1 is at a normal level, it mainly exerts an antioxidant effect, and when it is excessively elevated, it causes an accumulation of iron ions.

A proper cellular level of HMOX1 plays an antioxidative function to protect cells from ROS toxicity. However, its overexpression has pro-oxidant effects to induce ferroptosis of cells, which is dependent on intracellular iron accumulation and increased ROS content upon excessive activation of HMOX1.

-Curcumin   Activates the Nrf2 pathway leading to HO‑1 induction; known for its anti‑inflammatory and antioxidant effects.
-Resveratrol  Induces HO‑1 via activation of SIRT1/Nrf2 signaling; exhibits antioxidant and cardioprotective properties.
-Quercetin   Activates Nrf2 and related antioxidant pathways; contributes to anti‑oxidative and anti‑inflammatory responses.
-EGCG     Promotes HO‑1 expression through activation of the Nrf2/ARE pathway; also exhibits anti‑inflammatory and anticancer properties.
-Sulforaphane One of the most potent natural HO‑1 inducers; triggers Nrf2 nuclear translocation and upregulates a battery of phase II detoxifying enzymes.
-Luteolin    Induces HO‑1 via Nrf2 activation; may also exert anti‑inflammatory and neuroprotective effects in various cell models.
-Apigenin   Has been reported to induce HO‑1 expression partly via the MAPK and Nrf2 pathways; also known for anti‑inflammatory and anticancer activities.
Scientific Papers found: Click to Expand⟱
4726- Se,  Oxy,    Oxygen therapy accelerates apoptosis induced by selenium compounds via regulating Nrf2/MAPK signaling pathway in hepatocellular carcinoma
- in-vivo, HCC, NA
eff↝, NRF2↓, p‑p38↑, Apoptosis↑, eff↑, TumVol↓, other↝, toxicity↓, Dose↝, NRF2↝, HO-1↓, Catalase↓, SOD↓, e-pH↓, pH∅, MAPK↑, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

Catalase↓, 1,   HO-1↓, 1,   NRF2↓, 1,   NRF2↝, 1,   SOD↓, 1,  

Cell Death ⓘ

Apoptosis↑, 1,   MAPK↑, 1,   p‑p38↑, 1,  

Transcription & Epigenetics ⓘ

other↝, 1,  

Cellular Microenvironment ⓘ

pH∅, 1,   e-pH↓, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,   eff↑, 2,   eff↝, 1,  

Functional Outcomes ⓘ

toxicity↓, 1,   TumVol↓, 1,  
Total Targets: 16

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: HO-1, HMOX1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:173  Target#:597  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page